You have access
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications
Timothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, Zhenhua Miao, Yu Wang, Bin N Zhao, Trageen Baumgart, Rob Berahovich, Linda S Ertl, Andrew Pennell, Lisa Seitz, Shichang Miao, Solomon Ungashe, Zheng Wei, Dan Johnson, Landin Boring, Chia-Lin Tsou, Israel F Charo, Pirow Bekker, Thomas J Schall and Juan C Jaen
Journal of Pharmacology and Experimental Therapeutics January 2012, jpet.111.190918; DOI: https://doi.org/10.1124/jpet.111.190918